- 1. VIR ENCEPH ARTHROPOD NEC
- [ ] (UMLS (ICD9CM) C0153069) =Disease or Syndrome
| - 47. viroid
- [A group of pathogens comprising the smallest known agents of infectious disease. They are unencapsulated and are capable of replicating autonomously in susceptible cells. Positively identified viroids composed of single-stranded RNA have been isolated from higher plants, but the existence of DNA viroids pathogenic to animals is suspected. ( MSH )] (UMLS (CSP) C0042761) =Virus =microorganism;
=prion |
- 2. Vira-A
- (UMLS (NCI) C0699565) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
| - 48. virology
- [ ] (UMLS (CSP) C0042762) =Biomedical Occupation or Discipline
|
- 3. viracept
- [ ] (UMLS (CSP) C0525004) =Organic Chemical; Pharmacologic Substance
| - 49. Virology
- (UMLS (HL7) C1548007) =Intellectual Product =Diagnostic Service Section ID;
|
- 4. viral
- [Having to do with a virus. ( NCI )] (UMLS (NCI) C0521026) =Functional Concept
| - 50. Virorax
- (UMLS (NCI) C0920749) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
|
- 5. Viral Activity
- [Biological functions, activities, or processes of viral elements that support the viability, propagation, or maintenance of a virus. (NCI) ( NCI )] (UMLS (NCI) C0243052) =Natural Phenomenon or Process ;
| - 51. Virormone
- (UMLS (NCI) C0592254) =Steroid; Pharmacologic Substance ;
|
- 6. viral antigen variation
- [ ] (UMLS (CSP) C0599951) =Molecular Function
| - 52. Virosome
- [Virosomes are reconstituted influenza virus (A/Singapore) envelopes. The membrane of these vesicles consists of a spherical, unilamellar lipid bilayer. Purified influenza envelope glycoproteins (hemagglutinin HA and neuramindase NA) are inserted into the lipid bilayer. Virosomes with a bilayer consisting of neutral phospholipids can be used as an unspecific or a specific drug carrier system, while positively charged vesicles can be used as a transfer system for any genetic materials. ( NCI )] (UMLS (NCI) C0887910) Virosomes =Amino Acid, Peptide, or Protein; Lipid
|
- 7. viral carcinogenesis
- [process by which normal cells are transformed into cancer cells by means of a virus. ( CSP )] (UMLS (CSP) C0597645) =Neoplastic Process ;
=Cancer Induction;
=viral leukemogenesis | - 53. virtual
- [A patient encounter where the patient and the practitioner(s) are not in the same physical location. Examples include telephone conference, email exchange, robotic surgery, and televideo conference. ( HL7V3.0 )] (UMLS (HL7) C1553497) =Intellectual Product =ActEncounterCode;
|
- 8. VIRAL DISEASES ACCOMPANIED BY EXANTHEM
- (UMLS (ICD9CM) C0153062) =Disease or Syndrome
| - 54. virtual reality
- [An artificial environment generated by a computer that simulates the actual (real) world. Users can control VR programs through sensory loaded gloves and headsets, that are equipped with video monitors that give feeling of movement through 3-dimensional "virtual" environments. ( NCI )] (UMLS (CSP) C0871582) =Machine Activity ;
|
- 9. Viral Envelope Gene
- [The genes that encode the outer structure that encloses the nucleocapsids of some viruses and may contain host material. ( NCI )] (UMLS (NCI) C1336965) =Gene or Genome
| - 55. Virtual table query
- (UMLS (HL7) C1548128) =Idea or Concept =Message type;
|
- 10. Viral Esophagitis
- (UMLS (NCI) C0341110) =Disease or Syndrome
| - 56. Virudox
- (UMLS (NCI) C0731020) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
|
- 11. Viral Gastritis
- (UMLS (NCI) C0563238) =Disease or Syndrome ;
| - 57. virulence
- [degree of pathogenicity of a microorganism as indicated by the severity of the disease produced and its ability to invade the tissues of a host; the competence of any infectious agent to produce pathologic effects. ( CSP )] (UMLS (NCI) C0042765) =Biologic Function =Microbiology;
|
- 12. Viral Gastroenteritis
- (UMLS (NCI) C0318712) =Disease or Syndrome
| - 58. Virulizin
- [A substance that activates some types of immune system cells, and is being studied as a treatment for cancer. It belongs to the family of drugs called biological therapy agents. ( NCI )] (UMLS (NCI) C0254455) =Pharmacologic Substance; Immunologic Factor ;
|
- 13. Viral Gene
- [Genes of viral origin. ( NCI )] (UMLS (NCI) C0017376) =Gene or Genome
| - 59. virus
- [group of minute infectious agents characterized by a lack of independent metabolism and by the ability to replicate only within living host cells; have capsid, may have DNA or RNA (not both). ( CSP )] (UMLS (NCI) C0042776) =Virus =microorganism;
=bacterial virus;
DNA virus;
RNA virus |
- 14. Viral Genetics
- [heredity, especially the mechanisms of hereditary transmission and the variation of inherited characteristics among a virus or viruses; the genetic constitution of viruses. ( CSP )] (UMLS (NCI) C0597652) =Biomedical Occupation or Discipline =Microbial Genetics;
=genetic transduction | - 60. virus antigen
- [substances elaborated by viruses that have antigenic activity. ( CSP )] (UMLS (CSP) C0003342) =Immunologic Factor
|
- 15. Viral Genome
- [The complete genetic complement contained in a DNA or RNA molecule in a virus. ( MSH )] (UMLS (NCI) C0042720) =Gene or Genome ;
| - 61. virus assembly
- [coming together of the constituent parts of a virus particle; process can vary from autoassembly of protein subunits around the viral nucleic acid to assembly of complex viruses at cell membranes. ( CSP )] (UMLS (CSP) C0282629) =Biologic Function ;
=virus multiplication;
|
- 16. Viral Genotype Susceptibility
- (UMLS (HL7) C1697855) =Laboratory Procedure =Susceptibility Testing;
| - 62. virus characteristic
- [features that helps to identify, distinguish or describe recognizably; classification systems of viruses; includes infection routes, staining patterns, replication requirements, etc. ( CSP )] (UMLS (CSP) C0597650) =Organism Attribute =Microbiology;
=defective virus;
helper virus;
hepatitis virus;
insect virus;
oncogenic virus;
plant virus;
interfering virus;
virion;
simian virus;
neurotropic virus;
noncytopathogenic virus;
respiratory virus;
transforming virus;
viral rescue;
virus infection mechanism;
virus morphology;
prophage |
- 17. viral haemorrhagic septicemia virus
- [ ] (UMLS (CSP) C0318853) =Virus
| - 63. virus classification
- [used for taxonomic or other systematic or hierarchical virus classification systems. ( CSP )] (UMLS (CSP) C0597651) =Intellectual Product =microorganism classification;
|
- 18. VIRAL HEP CARRIER NOS
- (UMLS (ICD9CM) C0549126) =Finding
| - 64. virus core
- [ ] (UMLS (CSP) C0598995) =Nucleic Acid, Nucleoside, or Nucleotide; Amino Acid, Peptide, or Protein
|
- 19. Viral hepatitis
- (UMLS (ICPC) C0042721) (Viral hepatitis; HEPATITIS ZOLDURAGARRIA; Virus hepatit; Virus hepatitis; VIRUSHEPATIITTI; Hepatite virale; akute Virushepatitis; tzahevet medabeket (A,B,C); virus hepatitis; Epatite virale; INFEKSIOS HEPATITT; Hepatite viral; Hepatitis infecciosa; VIRUSHEPATIT) =Disease or Syndrome ;
=Body System, Gastrointestinal; Diagnosis/Diseases Component | - 65. virus culture
- [ ] (UMLS (CSP) C0200955) =Laboratory Procedure
|
- 20. Viral hepatitis B with hepatic coma
- [ ] (UMLS (ICD9CM) C0153076) =Disease or Syndrome
| - 66. virus cytopathogenic effect
- [visible morphologic changes in virus-infected cells effecting intracellular structures and cell functions, e.g. chromosomal aberrations, viral inclusion bodies, membrane permeability, and protein synthesis; do not confuse with CELL TRANSFORMATION. ( CSP )] (UMLS (CSP) C0010827) =Cell or Molecular Dysfunction ;
=virus infection mechanism;
|
- 21. Viral hepatitis B without mention of hepatic coma
- (UMLS (ICD9CM) C0700211) =Disease or Syndrome
| - 67. virus development
- [ ] (UMLS (CSP) C0599615) =Organism Function
|
- 22. Viral Laryngitis
- (UMLS (NCI) C0853195) =Disease or Syndrome
| - 68. virus DNA
- [DNA that makes up the genetic material of viruses. ( CSP )] (UMLS (CSP) C0012939) =Nucleic Acid, Nucleoside, or Nucleotide =deoxyribonucleic acid;
nucleocapsid |
- 23. viral latency
- [The ability of a pathogenic virus to lie dormant within a cell (latent infection). In eukaryotes, subsequent activation and viral replication is thought to be caused by extracellular stimulation of cellular transcription factors. Latency in bacteriophage is maintained by the expression of virally encoded repressors. ( MSH )] (UMLS (CSP) C0206188) =Organism Function
| - 69. virus entry
- [The entering of cells by viruses following VIRUS ATTACHMENT. This is achieved by ENDOCYTOSIS, by direct MEMBRANE FUSION of the viral membrane with the CELL MEMBRANE, or by translocation of the whole virus across the cell membrane. ( MSH )] (UMLS (CSP) C1537068) =Biologic Function ;
|
- 24. viral leukemia
- [leukemia (progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow) for which a virus is the etiological agent. ( CSP )] (UMLS (CSP) C0597646) =Neoplastic Process ;
=Blood (Leukemia);
virus related neoplasm/cancer =hairy cell leukemia;
acute T cell leukemia;
Friend leukemia | - 70. virus host interaction
- [Interactions, directly with the host cell macromolecular machinery, to allow virus replication. [ISBN:0781718325] ( GO )] (UMLS (CSP) C0599952) =Cell Function
|
- 25. viral leukemogenesis
- [process by which normal cells are transformed into leukemia by means of a virus. ( CSP )] (UMLS (CSP) C0597647) =Neoplastic Process ;
=viral carcinogenesis;
| - 71. virus identification
- [ ] (UMLS (CSP) C0599616) =Laboratory Procedure
|
- 26. viral leukoencephalitis
- [ ] (UMLS (CSP) C0599610) =Disease or Syndrome ;
| - 72. virus inactivation
- [Inactivation of viruses by non-immune related techniques. They include extremes of pH, HEAT treatment, ultraviolet radiation, IONIZING RADIATION; DESICCATION; ANTISEPTICS; DISINFECTANTS; organic solvents, and DETERGENTS. ( MSH )] (UMLS (CSP) C0599953) =Laboratory Procedure
|
- 27. Viral Load
- [The number of viral particles (usually HIV) in a sample of blood plasma. ( NCI )] (UMLS (NCI) C0376705) =Finding
| - 73. virus infection mechanism
- [multi-step process by which a virus binds to, enters, and replicates within a host cell; includes both surface and intracellular interactions between host and virus. ( CSP )] (UMLS (CSP) C0597653) =Organism Attribute =virus characteristic;
=virus cytopathogenic effect;
virus multiplication;
virus integration;
virus virus interaction;
|
- 28. viral myelinopathy
- [any virus disease of the myelin; degeneration of the white matter of the brain of viral etiology. ( CSP )] (UMLS (CSP) C0597648) =Disease or Syndrome ;
=Infection, Viral;
myelinopathy;
nervous system infection;
=Leukoencephalopathy, Progressive Multifocal;
Dawson's encephalitis;
| - 74. virus integration
- [naturally occurring process of insertion of viral DNA into the host genome; not a genetic technique. ( CSP )] (UMLS (CSP) C0085224) =Biologic Function =virus infection mechanism;
|
- 29. viral neoplasm
- [ ] (UMLS (CSP) C0872301) virus related neoplasm =Neoplastic Process ;
| - 75. virus load
- [measure of the concentration of a virus in the blood or other body fluids; used as a measure of the severity of a virus infection. ( CSP )] (UMLS (CSP) C1261478) =Laboratory Procedure ;
=Infection, Viral;
|
- 30. Viral Oncogene
- [Cancer-causing genes encoded in viral genomes. Usually denoted v-onc. ( NCI )] (UMLS (NCI) C1336966) =Gene or Genome
| - 76. virus morphology
- [form and structure of viruses. ( CSP )] (UMLS (CSP) C0597654) =Organism Attribute =virus characteristic;
=nucleocapsid;
coat (enveloped virus);
|
- 31. Viral Oncogene Protein
- [Proteins expressed by virally mutated genes that once played a normal role in the cell as a proto-oncogene. There are several different types of viral oncogene proteins, and the expression of these proteins contributes to a transformed phenotype in cells. ( NCI )] (UMLS (NCI) C0029015) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 77. virus multiplication
- [process of forming progeny virus from input virus; involves expression and replication of viral genomic nucleic acid and the assembly of progeny virus particles. ( CSP )] (UMLS (CSP) C0042774) =Organism Function =virus infection mechanism;
=provirus;
virus assembly;
|
- 32. Viral Phenotype Susceptibility
- (UMLS (HL7) C1698491) =Laboratory Procedure =Susceptibility Testing;
| - 78. virus pathogenesis
- [ ] (UMLS (CSP) C0920672) =Cell or Molecular Dysfunction ;
|
- 33. Viral Protein
- [proteins found in any species of virus. ( CSP )] (UMLS (NCI) C0042736) =Amino Acid, Peptide, or Protein; Biologically Active Substance =gene product;
=GAG Protein;
integrase;
HIV envelope protein | - 79. virus registry
- [ ] (UMLS (CSP) C1328966) =Manufactured Object; Intellectual Product
|
- 34. Viral Receptor
- [viruses must first bind to their target cell's surface before infection can proceed; this is mediated by specific molecular receptors for certain viral antigens, many of which have other known functions; e.g., the MHC-II receptor CD4 is also an HIV receptor. ( CSP )] (UMLS (NCI) C0034848) =Amino Acid, Peptide, or Protein; Receptor =Cell Surface Receptor;
| - 80. Virus Related Cancer
- [This category currently includes only malignancies in which there is a well documented association between the neoplastic process and a specific virus as a causative agent.--2003 ( NCI )] (UMLS (NCI) C0920673) Virus Related Malignancy;
Virus-Related Cancer;
Virus-Related Malignancy;
Virus-Related Malignant Neoplasm =Neoplastic Process ;
|
- 35. viral rescue
- [the reactivation of a defective virus either by recombination or by complementation of the defective functions. ( CSP )] (UMLS (CSP) C0597649) =Organism Attribute =virus characteristic;
| - 81. Virus Related Carcinoma
- (UMLS (NCI) C1336967) Virus-Related Carcinoma =Neoplastic Process
|
- 36. Viral Respiratory Tract Infection
- (UMLS (NCI) C0877203) =Disease or Syndrome
| - 82. virus related diabetes mellitus
- [diabetes mellitus that is caused or exacerbated by the presence of a virus in the body. ( CSP )] (UMLS (CSP) C0597655) =Disease or Syndrome =Diabete mellito;
Infection, Viral |
- 37. Viral Transport medium
- (UMLS (HL7) C1550094) =Biomedical or Dental Material ;
=Additive/Preservative;
| - 83. Virus Related Lymphoma
- (UMLS (NCI) C1336968) Virus-Related Lymphoma =Neoplastic Process
|
- 38. Viral Transport medium
- [Sucrose 74.6g, Potassium hydrogenphosphate 0.52g, L-glutamic acid 0.72g, Bovine serum albumin 5.0g, Gentamicin 50mg, Potassium dihydrogenphosphate 1.25g, L-15 medium 9.9L, Water to 10L. Maintain Virus viability. ( HL7V3.0 )] (UMLS (HL7) C1556115) =Intellectual Product =MaterialEntityAdditive;
| - 84. virus related neoplasm/cancer
- [human or animal neoplasms or cancers that are caused or exacerbated by the presence of a virus in the body. ( CSP )] (UMLS (CSP) C0597656) =Neoplastic Process =Infection, Viral;
infection related neoplasm/cancer =rabbit papilloma;
GARATXAK;
avian leukosis/sarcoma;
Lucke renal adenocarcinoma;
viral leukemia |
- 39. viral vaccine
- [suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease. ( CSP )] (UMLS (CSP) C0042742) =Pharmacologic Substance; Immunologic Factor =[IM100] VACCINES;
=flu vaccine;
measles;
poliomyelitis vaccine;
RABIES VACCINE;
smallpox;
hepatitis vaccine;
AIDS vaccine;
Herpesviridae vaccine;
paramyxovirus vaccine;
Pneumovirus vaccine;
rotavirus vaccine | - 85. virus resource
- [ ] (UMLS (CSP) C1328967) =Manufactured Object; Intellectual Product
|
- 40. viral vector development
- [ ] (UMLS (CSP) C0872302) =Biomedical Occupation or Discipline ;
| - 86. virus RNA
- [RNA that makes up the genetic material of viruses. ( CSP )] (UMLS (CSP) C0035736) =Nucleic Acid, Nucleoside, or Nucleotide =Ribonucleic acid;
nucleocapsid |
- 41. VIRAL WARTS NOS
- (UMLS (ICD9CM) C0343642) =Disease or Syndrome
| - 87. virus seed resource
- [ ] (UMLS (CSP) C1328968) =Manufactured Object; Intellectual Product
|
- 42. Viramide
- (UMLS (NCI) C0702029) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 88. virus tropism
- [ ] (UMLS (CSP) C0599954) =Organism Attribute
|
- 43. Viramune
- (UMLS (NCI) C0728726) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
| - 89. virus unmasking
- [ ] (UMLS (CSP) C0599612) =Organism Attribute
|
- 44. virilism
- [abnormal possession of mature masculine somatic characteristics by a girl, woman, or prepubescent; may be present at birth or may appear first later in life, depending on its cause; it may be relatively mild (hirsutism) or severe; commonly the result of gonadal or adrenocortical dysfunction, or may be produced by androgenic therapy. ( CSP )] (UMLS (CSP) C0042755) =Sign or Symptom ;
=adrenal disorder;
gonad disorder;
sex development disorder;
=hirsutism | - 90. virus virus interaction
- [refers to various types of interactions that can occur between two or more viruses. ( CSP )] (UMLS (CSP) C0597657) =Organism Function =virus infection mechanism;
|
- 45. Virilon
- (UMLS (NCI) C0724290) Virilon brand of testosterone 17 beta-cypionate =Steroid; Pharmacologic Substance; Hormone
| - 91. Virus-like Particle
- [A complex of the retrotransposon RNA genome, reverse transcriptase, integrase, and associated molecules required for reproduction and integration of the retrotransposon into the host genome; the main structural molecule of the nucleocapsid is often a gag protein homolog. [GOC:clt, PMID:10861903] ( GO )] (UMLS (NCI) C1325725) VLP;
=Cell Component ;
|
- 46. virion
- [the infectious unit of a virus. ( CSP )] (UMLS (CSP) C0042760) =Cell Component =virus characteristic;
| - 92. Virus-Related Sarcoma
- (UMLS (NCI) C1336969) =Neoplastic Process
|
home
